New Drug May Help MS

Multiple sclerosis is a debilitating disease, but there's hope for those who have suffered brain damage from the illness.  Alemtuzumab, a drug originally developed to treat leukaemia, may stop the progression of the MS and even enable the body's ability to repair previous brain damage. The drug helps patients with early stage active relapsing-remitting MS, which is the most common form of the disease. 

Researchers at the University of Cambridge stress that more research needs to be done and their results are not conclusive. However, the drug cut the number of attacks from the conduction by 74 percent among the 334 patients with early stage active relapsing-remitting MS who participated in one clinical trial. People in the trials also regain functions thought lost after taking the drug. 

Originally reported by the BBC.